Qualitis SA, a member of Optimapharm Group, is a Full-Service Clinical Research & Medical Consulting Organization. With a strong focus on people and standards, Qualitis was established in 2006 and has built upon the three milestones of business success: Uncompromising Quality, Commitment and Integrity.

After a 16-year business journey, Qualitis has become a leading CRO partner in the Greek market. In 2022, Qualitis became part of Optimapharm, a leading, mid-sized, full-service CRO working across Europe and North America, aiming to deliver new therapies to improve and save patients' lives. Optimapharm key priorities are our people and consistently exceeding our clients' expectations. With 27 offices strategically located across Europe, Optimapharm operates in 40 countries, giving unrivalled access to Patients and Investigators in all European countries and North America. 

In-depth expertise and long-standing experience, combined with a flexible and collaborative approach, allow optimization of design and planning; through its strong track record of delivery excellence and committed and stable project teams, Optimapharm has secured a high level of repeat business over the years.

To successfully plan your next trial, contact us at: request.proposal@optimapharm.eu

or complete the relevant form at: https://www.qualitis.gr/contact-details/contact-form-for-customers.

Qualitis SA, a member of Optimapharm Group